Pathalys Pharma
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4242 Six Forks Rd Ste 820, Raleigh, Nort...Website
www.pathalys.comRevenue
<$5 MillionIndustry
About Pathalys Pharma
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company dedicated to developing advanced therapeutics for the management of chronic kidney disease (CKD). The company focuses on addressing unmet needs in late-stage CKD, particularly through its investigational product, upacicalcet, a novel calcimimetic aimed at treating secondary hyperparathyroidism (SHPT). Pathalys Pharma aims to improve patient outcomes by providing innovative solutions that enhance the management of end-stage kidney disease. Their commitment to research and development is supported by significant funding and a team of experienced professionals.Explore more
Pathalys Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Pathalys Pharma
Compare insights from companies similar to Pathalys Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pathalys Pharma Tech Stack
A closer look at the technologies used by Pathalys Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pathalys Pharma
Sign Up For FreeTo access detailed company insights
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company dedicated to developing advanced therapeutics for the management of chronic kidney disease (CKD). The company focuses on addressing unmet needs in late-stage CKD, particularly through its investigational product, upacicalcet, a novel calcimimetic aimed at treating sec... Read More
